Trials / Unknown
UnknownNCT04262700
Customer Outcomes & Value Experiencing A New Monitoring Technology
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- LifeScan Scotland Ltd · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
To investigate whether novel insight features in new Blood Glucose Monitoring System (BGMs) can improve glycemic control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LifeScan's new BGMS | LifeScan new Blood Glucose Monitoring System (BGMS) |
Timeline
- Start date
- 2020-02-07
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2020-02-10
- Last updated
- 2020-09-09
Locations
2 sites across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04262700. Inclusion in this directory is not an endorsement.